Mark Miller, Vice President, Corporate Business Development, Lilly, presented at last year's World Orphan Drug Congress USA on the topic â€˜Leveraging licensing and acquisitions to enter orphan disease research successfully.'
Do you want to learn more about:
- Interest in orphan diseases and vision of the future
- Challenges that need to be overcome
- Strategy for entering the orphan disease area and implementing strategy
If so, you need to check out the video below: